Neurology Alert – November 1, 2008
November 1, 2008
View Issues
-
IV Thrombolysis 3-4.5 Hours After Stroke: Time for a Change?
Intravenous thrombolysis is safe and effective for the treatment of ischemic stroke in the time window of 3-4.5 hours after the onset of symptoms. -
Botulinum Toxin Type A in Painful Focal Neuropathy
There is promising evidence that botulinum toxin type A provides analgesia in patients with painful focal neuropathy independent of its neuromuscular blocking action. -
What Distinguishes Neuromyelitis Optica from Multiple Sclerosis?
Neuromyelitis optica (NMO) may be a unique central nervous system demyelinating disease with distinct clinical and MRI manifestations, as well as different immune and pathological characteristics as compared to multiple sclerosis (MS). -
Results of the PRoFESS Trial: Use Any Antiplatelet Agent and Get Back to the Basics
Aspirin plus extended-release dipyridamole and clopidogrel are both appropriate options to decrease disability from recurrent stroke; however, telmisartan does not lower risk of suffering a second stroke. -
Statins and Myasthenia
Statins may cause worsening symptoms in patients with myasthenia gravis. -
Pharmacology Watch
Ongoing safety review of tiotropium; raloxifene reduces the risk of endometrial cancer; one-day treatment with famciclovir may be as effective as 3-day treatment with valacyclovir; new Clinical Practice Guideline from the American College of Physicians regarding pharmacologic treatment for low bone density and osteoporosis; FDA Actions. -
Clinical Briefs in Primary Care supplement